PUBLICACIONES
- Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
- Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
- Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
- Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
- Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
- Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study
- ALDRESS: A Retrospective Pilot Study to Develop a Pharmacological Causality Algorithm for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)
- Safety and immunogenicity of Ad26.COV2.S in adults: A randomised, double-blind, placebo-controlled Phase 2a dose-finding study
- Clonal chromosomal mosaicism and loss of chromosome Y in elderly men increase vulnerability for SARS-CoV-2
- Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
- Developments in pharmacogenetics, pharmacogenomics, and personalized medicine
- Implementing pharmacogenetics in clinical trials: considerations about current methodological, ethical, and regulatory challenges
- Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
- Advancing pharmacogenetic testing in a tertiary hospital: a retrospective analysis after 10 years of activity
- Results of phase 2 randomized multi-center study to evaluate the safety and efficacy of infusion of memory T cells as adoptive therapy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia and/or lymphopenia (RELEASE NCT04578210)
![logoClinPharmacolWhite](http://clinpharmacolgroup.es/wp-content/uploads/2023/03/logoClinPharmacolWhite.png)
Hospital Universitario La Paz
Servicio de Farmacología Clínica – UCICEC
Horario:
Lunes a Jueves 8.00-17.00
Viernes 8.00 - 15.00
Teléfono: 91 207 14 66
Fax: 91 207 13 84
Email: ucicec.hulp@salud.madrid.org
© Copyright 2024 | ClinPharmaColGroup Todos los derechos reservados